Search Results - "Yasuba, Hirotaka"

Refine Results
  1. 1
  2. 2

    Role of eosinophilic chronic rhinosinusitis in switching to benralizumab treatment in mepolizumab responders by Hamada, Satoshi, Kobayashi, Yoshiki, Yasuba, Hirotaka

    “…There are currently three anti-interleukin-5 (IL-5) pathway-directed therapies: mepolizumab, reslizumab, and benralizumab. Of these, benralizumab was most…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Effect of nasally exhaling budesonide/formoterol dry powder inhaled at "fast" inspiratory flow on eosinophilic chronic rhinosinusitis by Hamada, Satoshi, Hira, Daiki, Kobayashi, Yoshiki, Yasuba, Hirotaka

    “…Budesonide (BUD)/formoterol (FM) dry powder inhaler has a feature that the fine particle fraction output is dependent on users' inspiratory flow rate. The aim…”
    Get full text
    Journal Article
  5. 5

    HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study by Kobayashi, Yoshiki, Yasuba, Hirotaka, Asako, Mikiya, Yamamoto, Takahisa, Takano, Hiroshi, Tomoda, Koichi, Kanda, Akira, Iwai, Hiroshi

    Published in Frontiers in immunology (25-09-2018)
    “…Eosinophilic chronic rhinosinusitis (ECRS) is a subtype of chronic rhinosinusitis with nasal polyps in Japanese. ECRS highly associated with asthma is a…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media by Satoshi Hamadaa, Eriko Oginob, Hirotaka Yasubac, d

    Published in Allergology International (01-07-2021)
    “…Dear Editor, Eosinophilic inflammation plays a crucial role in the development of not only severe asthma but also eosinophilic chronic rhinosinusitis (ECRS) or…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Nasal exhalation of inhaled beclomethasone hydrofluoroalkane-134a to treat chronic rhinosinusitis by Hamada, Satoshi, MD, Matsumoto, Hisako, MD, PhD, Kobayashi, Yoshiki, MD, PhD, Asako, Mikiya, MD, PhD, Yasuba, Hirotaka, MD, PhD

    “…Sinus computed tomography (CT) revealed mucosal thickening and opacification of the ethmoid sinuses, olfactory clefts, and maxillary sinuses bilaterally…”
    Get full text
    Journal Article
  10. 10

    Clinical option of omalizumab on refractory vasospastic angina with asthma and eosinophilic chronic rhinosinusitis by Hamada, Satoshi, MD, Tatsumi, Shuji, MD, Taniguchi, Tomohiko, MD, Yasuba, Hirotaka, MD, PhD

    “…Because she was unwilling to use oral corticosteroids, she was treated with omalizumab (Xolair; Genentech, San Francisco, Calif) 300 mg once a month without…”
    Get full text
    Journal Article
  11. 11

    Super-responder and clinical remission in patients with asthma on treatment with single biologic therapy or cycling therapy using dupilumab in a real-world setting by Hamada, Satoshi, Ogino, Eriko, Yasuba, Hirotaka

    “…Regarding the therapeutic target in asthma, super-responder status (SR) is a status without systemic corticosteroids. Recently, clinical remission (CR), being…”
    Get full text
    Journal Article
  12. 12

    Correlation between rheumatoid factor and peripheral eosinophil count in chronic eosinophilic pneumonia by KUDOU, Megumi, YASUBA, Hirotaka, KOBAYASHI, Yoshiki, HAMADA, Kazuyuki, KITA, Hideo

    Published in Respirology (Carlton, Vic.) (01-11-2006)
    “…:  The relationship between the blood level of rheumatoid factor (RF) and the peripheral blood eosinophil (Eo) count (white blood cells × %Eo, Eo count) in a…”
    Get full text
    Journal Article
  13. 13

    Favorable clinical course after discontinuation of omalizumab treatment in patients with allergic severe asthma: A real-world clinical practice by Hamada, Satoshi, Ogino, Eriko, Yasuba, Hirotaka

    Published in Respiratory investigation (01-09-2024)
    “…The success rate of omalizumab discontinuation is 50–75.5%. However, such data are scarce in Japan. We retrospectively investigated the clinical progression…”
    Get full text
    Journal Article
  14. 14

    Characteristics of Late-onset Asthma in Elderly Asthmatic Patients by Yasuba, Hirotaka, Kobayashi, Yoshiki, Kudou, Megumi, Hamada, Kazuyuki, Kita, Hideo

    Published in Allergology International (2005)
    “…We evaluated the characteristics of late-onset asthma in elderly patients with asthma, particularly concerning the relationship of IgE mediation and response…”
    Get full text
    Journal Article
  15. 15

    Critical role of CCL4 in eosinophil recruitment into the airway by Kobayashi, Yoshiki, Konno, Yasunori, Kanda, Akira, Yamada, Yoshiyuki, Yasuba, Hirotaka, Sakata, Yoshiko, Fukuchi, Mineyo, Tomoda, Koichi, Iwai, Hiroshi, Ueki, Shigeharu

    Published in Clinical and experimental allergy (01-06-2019)
    “…Summary Background Excessive eosinophil airway infiltration is a clinically critical condition in some cases. Eosinophilic pneumonia (EP) is a pulmonary…”
    Get full text
    Journal Article
  16. 16

    Elevation of the plasma level of RANTES during asthma attacks by Chihara, Junichi, Yasuba, Hirotaka, Tsuda, Akira, Urayama, Osamu, Saito, Norihiro, Honda, Kohei, Kayaba, Hiroyuki, Yamashita, Tetsuji, Kurimoto, Fumihiko, Yamada, Hidekazu

    Published in Journal of allergy and clinical immunology (01-12-1997)
    “…Background: RANTES is considered to play an important role in various immune and allergic disorders since it is a potent chemoattractant for inflammatory cells…”
    Get full text
    Journal Article Conference Proceeding
  17. 17

    Residual exhaled nitric oxide elevation in asthmatics is associated with eosinophilic chronic rhinosinusitis by Kobayashi, Yoshiki, Asako, Mikiya, Ooka, Hisashi, Kanda, Akira, Tomoda, Koichi, Yasuba, Hirotaka

    Published in The Journal of asthma (26-11-2015)
    “…Objective: Eosinophilic chronic rhinosinusitis (ECRS) is as a subgroup of chronic rhinosinusitis (CRS) with nasal polyps. ECRS is a refractory disease closely…”
    Get full text
    Journal Article
  18. 18

    Nasal nitric oxide improved by continuous positive airway pressure therapy for upper airway inflammation in obstructive sleep apnea by Hamada, Satoshi, Tatsumi, Shuji, Kobayashi, Yoshiki, Yasuba, Hirotaka

    Published in Sleep & breathing (01-05-2017)
    “…Purpose In this report, we examined the association between obstructive sleep apnea (OSA) and upper and lower airway inflammation based on nitric oxide (NO)…”
    Get full text
    Journal Article
  19. 19

    Replacement of SFC-DPI with SFC-MDI exhaled through the nose improves eosinophilic chronic rhinosinusitis in patients with bronchial asthma by Kobayashi, Yoshiki, Asako, Mikiya, Yamamoto, Takahisa, Yasuba, Hirotaka, Tomoda, Koichi, Kanda, Akira

    “…Eosinophilic chronic rhinosinusitis (ECRS), a subgroup of chronic rhinosinusitis with nasal polyps, is a refractory disease closely associated with bronchial…”
    Get full text
    Journal Article
  20. 20

    Serum rheumatoid factor and peripheral blood eosinophil counts in patients with bronchial asthma by Kobayashi, Yoshiki, Yasuba, Hirotaka, Kita, Hideo, Hamada, Kazuyuki, Chihara, Junichi

    Published in Arerugi (01-12-2004)
    “…These days some reports say that bronchial asthma, especially severe asthma, is systemic inflammatory and its severity correlates with eosinophil counts. Some…”
    Get more information
    Journal Article